Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Bianca F. Middleton"'
Publikováno v:
Microbiology Australia, Vol 43, Iss 3, Pp 113-116 (2022)
Aboriginal and Torres Strait Islander people living in rural and remote Australia have lower vaccine coverage rates and experience higher rates of notification and hospitalisations for vaccine preventable diseases than non-Aboriginal people. This pap
Externí odkaz:
https://doaj.org/article/d17e480bc6bd47b492a4484467e71466
Publikováno v:
EClinicalMedicine, Vol 54, Iss , Pp 101687- (2022)
Summary: Background: Oral rotavirus vaccines have lower effectiveness in high child mortality settings. We evaluated the impact of additional dose(s) schedules of rotavirus vaccine on vaccine immunogenicity and reduction in episodes of gastroenteriti
Externí odkaz:
https://doaj.org/article/de40a290995b47dca86090f1f154289d
Autor:
Bianca F. Middleton, Margie Danchin, Helen Quinn, Anna P. Ralph, Nevada Pingault, Mark Jones, Marie Estcourt, Tom Snelling
Publikováno v:
Pathogens, Vol 9, Iss 10, p 790 (2020)
Background: A widespread G2P[4] rotavirus epidemic in rural and remote Australia provided an opportunity to evaluate the performance of Rotarix and RotaTeq rotavirus vaccines, ten years after their incorporation into Australia’s National Immunisati
Externí odkaz:
https://doaj.org/article/3a9699a323a44005a2d1eceb5d11de25
Autor:
Wuji Zhang, Lukasz Kedzierski, Brendon Y. Chua, Mark Mayo, Claire Lonzi, Vanessa Rigas, Bianca F. Middleton, Hayley A. McQuilten, Louise C. Rowntree, Lilith F. Allen, Ruth A. Purcell, Hyon-Xhi Tan, Jan Petersen, Priyanka Chaurasia, Francesca Mordant, Mikhail V. Pogorelyy, Anastasia A. Minervina, Jeremy Chase Crawford, Griffith B. Perkins, Eva Zhang, Stephanie Gras, E. Bridie Clemens, Jennifer A. Juno, Jennifer Audsley, David S. Khoury, Natasha E. Holmes, Irani Thevarajan, Kanta Subbarao, Florian Krammer, Allen C. Cheng, Miles P. Davenport, Branka Grubor-Bauk, P. Toby Coates, Britt Christensen, Paul G. Thomas, Adam K. Wheatley, Stephen J. Kent, Jamie Rossjohn, Amy W. Chung, John Boffa, Adrian Miller, Sarah Lynar, Jane Nelson, Thi H. O. Nguyen, Jane Davies, Katherine Kedzierska
Publikováno v:
Nature Immunology. 24:966-978
High-risk groups, including Indigenous people, are at risk of severe COVID-19. Here we found that Australian First Nations peoples elicit effective immune responses to COVID-19 BNT162b2 vaccination, including neutralizing antibodies, receptor-binding
Publikováno v:
Microbiology Australia. 43:113-116
Aboriginal and Torres Strait Islander people living in rural and remote Australia have lower vaccine coverage rates and experience higher rates of notification and hospitalisations for vaccine preventable diseases than non-Aboriginal people. This pap
Autor:
Bianca F. Middleton, Margie Danchin, Nigel A. Cunliffe, Mark A. Jones, Karen Boniface, Carl D. Kirkwood, Sarah Gallagher, Lea-Ann Kirkham, Caitlyn Granland, Monica McNeal, Celeste Donato, Nada Bogdanovic-Sakran, Amanda Handley, Julie E. Bines, Thomas L. Snelling
Publikováno v:
Vaccine.
Autor:
Bianca F. Middleton, Margie Danchin, Nigel A. Cunliffe, Mark A. Jones, Karen Boniface, Carl D. Kirkwood, Sarah Gallagher, Lea-Ann Kirkham, Caitlyn Granland, Monica McNeal, Celeste Donato, Nada Bogdanovic-Sakran, Amanda Handley, Julie E. Bines, Thomas L. Snelling
BackgroundHigh rates of breakthrough rotavirus gastroenteritis have been reported among Aboriginal children living in rural and remote Australia despite receipt of two doses of oral rotavirus vaccine. Histo-blood group antigens (HBGAs) may mediate ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcf9d556a93187065ff4b4a1e33765ac
https://doi.org/10.1101/2022.11.24.22282699
https://doi.org/10.1101/2022.11.24.22282699
Publikováno v:
SSRN Electronic Journal.
Autor:
Bianca F Middleton, Margie Danchin, Mark A Jones, Amanda J Leach, Nigel Cunliffe, Carl D Kirkwood, Jonathan Carapetis, Sarah Gallagher, Lea-Ann Kirkham, Caitlyn Granland, Monica McNeal, Julie A Marsh, Claire S Waddington, Thomas L Snelling
Publikováno v:
The Journal of infectious diseases. 226(9)
Background Rotarix (GlaxoSmithKline) oral rotavirus vaccine is licensed as 2 doses in the first 6 months of life. In settings with high child mortality rates, clinical protection conferred by 2 doses of Rotarix is reduced. We assessed vaccine immune
Autor:
Sarah Gallagher, Carl D. Kirkwood, Tom Snelling, Claire S. Waddington, Mark Jones, Margie Danchin, Jonathan R. Carapetis, Nigel A. Cunliffe, Amanda J. Leach, Monica M. McNeal, Bianca F Middleton, Caitlyn Granland, Julie A. Marsh, Lea-Ann S. Kirkham
BackgroundThe oral rotavirus vaccine, Rotarix (GlaxoSmithKline), is licensed for use in infants as two doses in the first six months of life. For infants living in settings with high child-mortality, and also for rural and remote Australian Aborigina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bbdbb69f55d7ede9d683e30416eb888
https://doi.org/10.1101/2021.09.26.21264122
https://doi.org/10.1101/2021.09.26.21264122